Elsevier's Reference Module and Pathway Studio Win SIIA CODiE Awards
17 juin 2015 09h00 HE
|
Elsevier, Inc.
WALTHAM, MA--(Marketwired - June 17, 2015) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that two of its content products...
Newly Published Results Support Clinical Validity of Quantose IGT(TM) Diabetes Test
20 janv. 2015 14h28 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced that results from a study of its Quantose IGT™ test were recently...
Metabolon's Platform for Clinical Triaging of Inborn Errors of Metabolism Verified by Baylor College of Medicine
22 oct. 2014 11h46 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C. and HOUSTON, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that its Global Metabolomic-Assisted Pathway Screen (MAPS)...
Metabolon's Quantose(TM) Prediabetes Tests Now Available in Europe Through Collaboration With Metdia Biotech
17 sept. 2014 11h05 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it has partnered with Metdia Biotech, S.L. to commercialize its...
Metabolon and Baylor College of Medicine Partner to Launch Global Metabolomic-Assisted Pathway Screen (MAPS) for Inborn Errors of Metabolism
03 sept. 2014 15h10 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C. and HOUSTON, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc. and Baylor College of Medicine announced today that they have entered into a two-year, exclusive agreement...
Metabolon to Sponsor Study at Geisinger Medical Center With Quantose IR to Monitor Prediabetes Therapy
23 juin 2014 16h16 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 23, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it will sponsor a pilot study to evaluate its Quantose IRTM test...
Metabolon Announces Quantose IR Test Launched in Mexico to Help Prevent Type 2 Diabetes
04 juin 2014 15h34 HE
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 4, 2014 (GLOBE NEWSWIRE) -- Metabolon, a global leader in metabolomics, announced today that its Quantose IR™ prediabetes test is now available to physicians...
Global Metabolomics Market By Applications and Indications
20 nov. 2013 09h37 HE
|
Research and Markets
Dublin, Nov. 20, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/2r3q8d/metabolomics)
has announced the addition of the "Metabolomics
(Biomarker...
HEPREGEN LAUNCHES FIRST MONKEY HEPATOPACTM ASSAY KITS AT ANNUAL USER GROUP MEETING
29 oct. 2013 10h47 HE
|
Hepregen
CAMBRIDGE, MASS., Oct. 29, 2013 (GLOBE NEWSWIRE) --
Today, at the Company's annual User Group Meeting, Hepregen Corporation, leader in the development of next generation HepatoPacTM and...